Insulet | PODD - Stock

Stock Price
188.31
Daily Change
-1.25 -0.66%
Monthly
-9.47%
Yearly
-27.44%
Q2 Forecast
185.50

Insulet reported $452.6M in Stock for its fiscal quarter ending in December of 2025.





Stock Change Date
Abbott USD 6.49B 220M Dec/2025
Align Technology USD 228.16M 15.59M Sep/2025
AtriCure USD 78.49M 459K Dec/2025
Avanos Medical USD 148M 2.6M Dec/2025
Baxter International USD 2.23B 228M Dec/2025
Becton, Dickinson and Co. USD 4.08B 191M Dec/2025
Boston Scientific USD 2.94B 22M Dec/2025
Cardinal Health USD 20.12B 2.56B Dec/2025
Cooper Companies USD 846M 35M Sep/2025
Dexcom USD 629.1M 25M Dec/2025
Edwards Lifesciences USD 1.13B 14.7M Dec/2025
Eli Lilly USD 13.74B 1.56B Dec/2025
Globus Medical USD 759.28M 12.26M Dec/2025
ICU Medical USD 615.86M 6.58M Dec/2025
Inogen USD 25.08M 762K Sep/2025
Insulet USD 452.6M 6.3M Dec/2025
Integra LifeSciences USD 492.73M 3.63M Dec/2025
J&J USD 14.58B 392M Mar/2026
Masimo USD 338.6M 20.1M Sep/2025
Medtronic USD 6.31B 153M Dec/2025
Merit Medical Systems USD 333.7M 7.15M Dec/2025
Roche Holding CHF 7.6B 9M Jun/2025
Solventum Corp USD 1.07B 17M Dec/2025
Stryker USD 5.31B 60M Dec/2025
Tandem Diabetes Care USD 128.77M 8.51M Dec/2025
Teleflex USD 802.46M 108.78M Sep/2025
West Pharmaceutical Services USD 452.6M 8.7M Mar/2026
Zimmer Biomet Holdings USD 2.29B 197.3M Dec/2025